B van den Hoonaard

Suggest Changes
Learn More
BACKGROUND The reduction of treatment-related toxic effects is the main goal in the current trials of the German Hodgkin Study Group (GHSG). In this regard, the protection of the ovarian reserve in(More)
  • 1